Electra Therapeutics, Inc. (ETRA)
NASDAQ: ETRA · Real-Time Price · USD
8.63
+0.28 (3.35%)
Nov 18, 2026, 10:04 AM EST - Market open
Electra Therapeutics Market Cap
Electra Therapeutics has a market cap or net worth of $541.68 million as of November 18, 2026. It is the 13,775th most valuable company in the world and the 2,642nd biggest in the United States.
Market Cap
541.68M
Enterprise Value
445.94M
1-Year Change
n/a
Global Rank
Country Rank
#2,642 United States
Category
ChartMarket Cap Chart
Since the IPO on September 18, 2026, Electra Therapeutics's market cap has decreased from $916.50M to $541.68M, a decrease of -40.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 541.68M | 3.85% |
| Nov 16, 2026 | 521.59M | -6.00% |
| Nov 13, 2026 | 554.86M | -2.96% |
| Nov 12, 2026 | 571.81M | -3.60% |
| Nov 11, 2026 | 593.15M | 18.27% |
| Nov 10, 2026 | 501.51M | -2.80% |
| Nov 9, 2026 | 515.94M | 5.38% |
| Nov 6, 2026 | 489.58M | 6.12% |
| Nov 5, 2026 | 461.34M | -7.78% |
| Nov 4, 2026 | 500.25M | -1.24% |
| Nov 3, 2026 | 506.53M | 10.40% |
| Nov 2, 2026 | 458.83M | -9.75% |
| Oct 30, 2026 | 508.41M | -6.25% |
| Oct 29, 2026 | 542.31M | -3.79% |
| Oct 28, 2026 | 563.65M | 5.40% |
| Oct 27, 2026 | 534.77M | 1.79% |
| Oct 26, 2026 | 525.36M | -3.90% |
| Oct 23, 2026 | 546.70M | -5.84% |
| Oct 22, 2026 | 580.59M | 2.21% |
| Oct 21, 2026 | 568.04M | 2.72% |
| Oct 20, 2026 | 552.98M | 2.32% |
| Oct 19, 2026 | 540.42M | -1.60% |
| Oct 16, 2026 | 549.21M | - |
| Oct 15, 2026 | 549.21M | -2.13% |
| Oct 14, 2026 | 561.14M | 3.83% |
| Oct 13, 2026 | 540.42M | -7.62% |
| Oct 12, 2026 | 584.99M | 3.10% |
| Oct 9, 2026 | 567.41M | -1.09% |
| Oct 8, 2026 | 573.69M | -0.22% |
| Oct 7, 2026 | 574.95M | -6.72% |
| Oct 6, 2026 | 616.37M | 0.82% |
| Oct 5, 2026 | 611.35M | -6.08% |
| Oct 2, 2026 | 650.89M | -2.90% |
| Oct 1, 2026 | 670.35M | -5.07% |
| Sep 30, 2026 | 706.13M | -0.88% |
| Sep 29, 2026 | 712.40M | 0.27% |
| Sep 28, 2026 | 710.52M | -1.99% |
| Sep 25, 2026 | 724.96M | -2.28% |
| Sep 24, 2026 | 741.91M | -6.71% |
| Sep 23, 2026 | 795.26M | -6.98% |
| Sep 22, 2026 | 854.89M | -2.16% |
| Sep 21, 2026 | 873.72M | -4.67% |
| Sep 18, 2026 | 916.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 559.34M |
| Crescent Biopharma | 558.13M |
| ArriVent BioPharma | 552.92M |
| Orchestra BioMed Holdings | 548.57M |
| Ginkgo Bioworks Holdings | 539.28M |
| Aclaris Therapeutics | 536.11M |
| Valneva SE | 534.63M |
| Helus Pharma | 526.03M |